EGM
AVDL

Engineers Gate Manager’s Avadel Pharmaceuticals AVDL Stock Holding History

Engineers Gate Manager’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,357
Closed -$245K – 2176
2025
Q4 		$245K Sell
11,357
-23,374
-67% -$454K ﹤0.01% 1726
2025
Q3 		$530K Buy
34,731
+5,032
+17% +$65.5K 0.01% 1491
2025
Q2 		$263K Sell
29,699
-27,778
-48% -$244K ﹤0.01% 1785
2025
Q1 		$450K Buy
57,477
+6,410
+13% +$53.7K 0.01% 1503
2024
Q4 		$537K Buy
51,067
+36,149
+242% +$439K 0.01% 1378
2024
Q3 		$196K Buy
+14,918
New +$227K ﹤0.01% 1808
2022
Q2 		– Sell
-11,500
Closed -$79K – 1894
2022
Q1 		$79K Buy
+11,500
New +$79.1K ﹤0.01% 1734
2021
Q3 		– Sell
-13,800
Closed -$93K – 1634
2021
Q2 		$93K Buy
+13,800
New +$110K 0.01% 1507
2020
Q4 		– Sell
-26,100
Closed -$132K – 1687
2020
Q3 		$132K Buy
26,100
+4,900
+23% +$35.7K 0.01% 1511
2020
Q2 		$171K Buy
+21,200
New +$187K 0.01% 1485
2020
Q1 		– Sell
-21,600
Closed -$163K – 1558
2019
Q4 		$163K Buy
+21,600
New +$114K 0.01% 1501

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Engineers Gate Manager's AVDL Position: Q1 2026 in Review

Engineers Gate Manager sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 11,357 shares — an estimated $245K sold.

Engineers Gate Manager first reported a position in AVDL in Q4 2019 and held it in 11 quarters. The position peaked at $537K in Q4 2024. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Engineers Gate Manager reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 11,357 Avadel Pharmaceuticals shares in Q1 2026, an estimated $245K.
  • Engineers Gate Manager first reported a position in Avadel Pharmaceuticals in Q4 2019 and held it in 11 quarters.
  • Engineers Gate Manager's Avadel Pharmaceuticals position peaked at $537K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.